Institutional Ownership
Disc Medicine Inc
CUSIP 254604101COMIRONQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
16.6%
Max % of class reported
Institutional Holders
197
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Jan 7, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 7, 2026 | Ra Capital Management, L.P. | 13G | 5.9% | 2.23M | SEC |
| 2 | Dec 17, 2025 | Atlas Venture Fund X, L.P. | 13D/A | 2.2% | — | SEC |
| 3 | Nov 5, 2025 | Fmr LLC | 13G/A | 14.1% | 4.91M | SEC |
| 4 | Oct 22, 2025 | Ai Dmi LLC | 13D/A | 8.0% | — | SEC |
| 5 | Aug 15, 2025 | Atlas Venture Fund X, L.P. | 13D/A | 3.1% | — | SEC |
| 6 | Aug 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 3.0% | 1.03M | SEC |
| 7 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 4.1% | 1.43M | SEC |
| 8 | Aug 7, 2025 | Fmr LLC | 13G/A | 12.2% | 4.22M | SEC |
| 9 | May 15, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 3.5% | 9.23B | SEC |
| 10 | May 12, 2025 | Wellington Management Group LLP | 13G | 6.8% | 2.34M | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Disc Medicine Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 5.59M | $357.23M |
| 2 | Ra Capital Management, L.P. | 2.45M | $156.67M |
| 3 | Blackrock, Inc. | 2.27M | $145.39M |
| 4 | Wellington Management Group LLP | 1.74M | $110.96M |
| 5 | State Street Corp | 1.70M | $108.59M |
| 6 | Atlas Venture Life Science Advisors, LLC | 1.51M | $96.80M |
| 7 | Frazier Life Sciences Management, L.P. | 1.35M | $86.63M |
| 8 | Tcg Crossover Management, LLC | 1.34M | $85.80M |
| 9 | Jpmorgan Chase & Co | 1.37M | $83.36M |
| 10 | Bvf Inc/Il | 1.27M | $81.35M |